Betoptic Suspension 2.5 mg/ml (betaxolol) · CNK 1073899

Product information

Betoptic Suspension 2.5 mg/ml
5 ml
betaxolol
1073899
8.86 / 10
Locked

Product properties

63659-18-7
S01ED02
Novartis Pharma
Eye drops, suspension
BE160334
07612797422700
M1
Public
160334-01

Pharmacist Assessment

Normally available

This product has good current availability (score 8.86/10) and is historically stable (score 🔒/10). No action required.

Note: commercialization of this product will be stopped on 31/07/2026.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 18 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Planned
From 31/07/2026

Commercial reasons

Adaptation of the treatment is possible
Available Active
Until 30/07/2026

Composition

7 ingredients

Substance Type Strength CAS
Active ingredient
2.8 mg/g
63659-19-8
Excipient
Excipient
4 mg/mL
Excipient
0.1 mg
Excipient
45 mg/mL
Excipient
Excipient
2.5 mg/mL

Additional information

Availability statistics

Available
0 days
3
0